Literature DB >> 3496470

Suppression and treatment of urinary tract infection in patients with an intermittently catheterized neurogenic bladder.

J L Mohler, D L Cowen, R C Flanigan.   

Abstract

We evaluated the optimal means of prevention and treatment of urinary tract infections in 46 patients with an intermittently catheterized neurogenic bladder. Suppression with nightly 160 mg. trimethoprim and 800 mg. sulfamethoxazole compared to placebo showed no difference in the rate of symptomatic or total urinary tract infections. Symptomatic urinary tract infections occurred at the same rate whether routine asymptomatic infections were treated or not. Three-day antibiotic treatment of urinary tract infections showed no decrease in the frequency of symptomatic or total urinary tract infections compared to 10-day therapy. The frequency of post-treatment urinary tract infection persistence, relapse and cure was identical in both groups. Suppressive antibiotics, treatment of asymptomatic urinary tract infections and full course antibiotic therapy offered no advantage over placebo, treatment of symptomatic urinary tract infection only and short course therapy in the management of urinary tract infection in patients with an intermittently catheterized neurogenic bladder.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3496470     DOI: 10.1016/s0022-5347(17)43138-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  20 in total

1.  Symptomatic urinary tract infections after surgery for prolapse and/or incontinence.

Authors:  Gary Sutkin; Marianna Alperin; Leslie Meyn; Harold C Wiesenfeld; Rennique Ellison; Halina M Zyczynski
Journal:  Int Urogynecol J       Date:  2010-03-31       Impact factor: 2.894

2.  Antibacterial agents and urinary tract infection: a paradox.

Authors:  R Maskell
Journal:  Br J Gen Pract       Date:  1992-04       Impact factor: 5.386

Review 3.  [Single-use intermittent catheterisation].

Authors:  U Grigoleit; J Pannek; M Stöhrer
Journal:  Urologe A       Date:  2006-02       Impact factor: 0.639

4.  Prophylactic antibiotics to prevent urinary tract infection during clean intermittent self-catheterization (CISC) for management of voiding dysfunction after prolapse and incontinence surgery: a decision analysis.

Authors:  Gary Sutkin; Jerry L Lowder; Kenneth J Smith
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-04-10

5.  Virulence properties of Escherichia coli 83972, a prototype strain associated with asymptomatic bacteriuria.

Authors:  R A Hull; D C Rudy; W H Donovan; I E Wieser; C Stewart; R O Darouiche
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

6.  A 5-day antibiotic course for treatment of intermittent catheter-associated urinary tract infection in patients with spinal cord injury.

Authors:  Jean-Gabriel Previnaire; Morgane Le Berre; Elisabeth Hode; Vincent Dacquet; Hemanou Bordji; Pierre Denys; Jean-Marc Soler
Journal:  Spinal Cord Ser Cases       Date:  2017-05-11

7.  Treatment of complicated urinary tract infections with lomefloxacin compared with that with trimethoprim-sulfamethoxazole.

Authors:  L E Nicolle; T J Louie; J Dubois; A Martel; G K Harding; C P Sinave
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

Review 8.  May we go on with antibacterial prophylaxis for urinary tract infections?

Authors:  R Beetz
Journal:  Pediatr Nephrol       Date:  2005-10-21       Impact factor: 3.714

9.  Complicated urinary tract infection in adults.

Authors:  L E Nicolle
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-11       Impact factor: 2.471

Review 10.  [Urological problems in patients with meningomyelocele. Diagnostic studies and management].

Authors:  R Stein; A Schröder; R Beetz; A Ermert; D Filipas; M Fisch; M Goepel; I Körner; B Schönberger; C Sparwasser; M Stöhrer; J W Thüroff
Journal:  Urologe A       Date:  2007-12       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.